Nils O. Elander

Region ÖStergötland
Linkoeping, E, SE 
Clinical Trials:Currently Recruiting for 2 Trials
Region ÖStergötland
Linkoeping, E, SE 

Overview

Nils Elander practices practicing medicine in Linkoeping, Sweden.

His clinical expertise encompasses Agranulocytosis, Febrile Neutropenia, Pancreatic Cancer, and Melanoma.

He is actively involved in clinical research, co-authoring 36 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Region Östergötland
Linkoeping, E, Sweden
Other Locations
Stockholm, AB 10691, Sweden
Norrkoeping, E, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

ProBio: An Outcome-adaptive and Randomized Multi-arm Biomarker Driven Study in Patients With Metastatic Prostate Cancer
ProBio: An Outcome-adaptive and Randomized Multi-arm Biomarker Driven Study in Patients With Metastatic Prostate Cancer
Enrollment Status: Recruiting
Publish Date: April 09, 2025
Intervention Type: Drug
Study Drugs: Enzalutamide, Abiraterone, Carboplatin, Cabazitaxel, Docetaxel, Radium Chloride Ra-223
Study Phase: Phase 3
A Prospective Randomized Multicenter Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of Stage IIb-c and III Cutaneous Malignant Melanoma
A Prospective Randomized Multicenter Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of Stage IIb-c and III Cutaneous Malignant Melanoma
Enrollment Status: Recruiting
Publish Date: December 16, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
A Randomized, Double-Blind, Adaptive, Phase II/III Study of GSK3359609 in Combination With Pembrolizumab and 5FU-Platinum Chemotherapy Versus Placebo in Combination With Pembrolizumab Plus 5FU-Platinum Chemotherapy for First-Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
A Randomized, Double-Blind, Adaptive, Phase II/III Study of GSK3359609 in Combination With Pembrolizumab and 5FU-Platinum Chemotherapy Versus Placebo in Combination With Pembrolizumab Plus 5FU-Platinum Chemotherapy for First-Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Enrollment Status: Terminated
Publish Date: October 09, 2024
Intervention Type: Drug
Study Drugs: Feladilimab, Pembrolizumab, Fluorouracil, Cisplatin, Carboplatin
Study Phase: Phase 3
A Randomized, Double-blind, Adaptive, Phase II/III Study of GSK3359609 or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1 Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
A Randomized, Double-blind, Adaptive, Phase II/III Study of GSK3359609 or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1 Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Enrollment Status: Terminated
Publish Date: July 10, 2024
Intervention Type: Drug
Study Drugs: Feladilimab, Pembrolizumab
Study Phase: Phase 3
View 2 Less Clinical Trial

36 Total Publications

Quantification of Ki-67 labeling index in pediatric brain tumor immunohistochemistry images.
Quantification of Ki-67 labeling index in pediatric brain tumor immunohistochemistry images.
Journal: Journal of neuropathology and experimental neurology
Published: March 10, 2026

Frequently Asked Questions about Nils O. Elander

Is Nils O. Elander a top-rated expert for Agranulocytosis?

MediFind is an objective health platform that identifies experts based on real-world data. Nils O. Elander is classified as an Experienced expert for Agranulocytosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Nils O. Elander participate in research or clinical trials?

Yes. Nils O. Elander has published 36 articles and abstracts on conditions like Agranulocytosis. You can view a list of Nils O. Elander's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Elander's expertise for a condition
ConditionClose
        View All 12 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile